Evidence map›Paper›PMID 39896084›Full record

ArticleAsian bioethics review2025

Assessing Risk in Implementing New Artificial Intelligence Triage Tools-How Much Risk is Reasonable in an Already Risky World?

Alexa Nord-Bronzyk, Julian Savulescu, Angela Ballantyne, Annette Braunack-Mayer, Pavitra Krishnaswamy, Tamra Lysaght, Marcus E H Ong, Nan Liu, Jerry Menikoff, Mayli Mertens and 1 more

Abstract read
In one paragraph

Article in Asian bioethics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexa Nord-BronzykCentre for Biomedical Ethics, National University of Singapore, Singapore.ORCID 0009-0006-8364-9009
Julian SavulescuCentre for Biomedical Ethics, National University of Singapore, Singapore.
Angela BallantyneUniversity of Otago, Wellington, New Zealand.
Annette Braunack-MayerSchool of Health and Society, University of Wollongong, Wollongong, Australia.
Pavitra KrishnaswamyInstitute for Infocomm Research, Agency for Science, Technology and Research (A*STAR), Singapore.
Tamra LysaghtSydney Health Ethics, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Marcus E H OngDepartment of Emergency Medicine, Singapore General Hospital, Singapore.
Nan LiuCenter for Quantitative Medicine, Duke-NUS Medical School, Singapore.
Jerry MenikoffCentre for Biomedical Ethics, National University of Singapore, Singapore.
Mayli MertensDepartment of Philosophy, University of Antwerp, Antwerp, Belgium.
Michael DunnCentre for Biomedical Ethics, National University of Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Risk prediction in emergency medicine (EM) holds unique challenges due to issues surrounding urgency, blurry research-practise distinctions, and the high-pressure environment in emergency departments (ED). Artificial intelligence (AI) risk prediction tools have been developed with the aim of streamlining triaging processes and mitigating perennial issues affecting EDs globally, such as overcrowding and delays. The implementation of these tools is complicated by the potential risks associated with over-triage and under-triage, untraceable false positives, as well as the potential for the biases of healthcare professionals toward technology leading to the incorrect usage of such tools. This paper explores risk surrounding these issues in an analysis of a case study involving a machine learning triage tool called the Score for Emergency Risk Prediction (SERP) in Singapore. This tool is used for estimating mortality risk in presentation at the ED. After two successful retrospective studies demonstrating SERP's strong predictive accuracy, researchers decided that the pre-implementation randomised controlled trial (RCT) would not be feasible due to how the tool interacts with clinical judgement, complicating the blinded arm of the trial. This led them to consider other methods of testing SERP's real-world capabilities, such as ongoing-evaluation type studies. We discuss the outcomes of a risk-benefit analysis to argue that the proposed implementation strategy is ethically appropriate and aligns with improvement-focused and systemic approaches to implementation, especially the learning health systems framework (LHS) to ensure safety, efficacy, and ongoing learning.

Indexed as

Artificial intelligenceImplementationRiskTriage

Identifiers

PMID39896084
PMCPMC11785855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.